Delivery Order SPE2DB20D3101-SPE2DB22FH1Q7
- Not listed
- This federal contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin products to the U.S. Defense Logistics Agency (DLA). The $2,735.86 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, to the Defense Logistics Agency (DLA). The $1,662.72 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2022, with a completion date of August 10, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, an insulin medication, to the Defense Logistics Agency (DLA). The $1,066.41 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 28, 2025. The contract has an ultimate completion date of March 3, 2025 and is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus SoloStar, a 100 unit/mL 3mL insulin product. The $1,594.26 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,147.93, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,977.56 firm fixed-price delivery order contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of June 23, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $4,091.20 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,187.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a critical insulin medication. It is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, to the Defense Logistics Agency (DLA), which is a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis for a ceiling value of $3,864.54. The award has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH1Q7Delivery Order
This federal contract award is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin medication, awarded by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The $2,966.51 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, has established itself as a key vendor for federal healthcare programs, particularly within the DLA and Department of Justice, delivering essential medications, medical devices, and supplies across various therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/19/21 |